Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$908K Sell
25,396
-34,604
-58% -$1.24M 2.11% 20
2019
Q2
$2.1M Hold
60,000
3.82% 13
2019
Q1
$2.06M Hold
60,000
3.66% 13
2018
Q4
$1.92M Buy
+60,000
New +$2.26M 3.33% 17

Other funds holding SNV

Clover Partners's SNV Position: Q3 2019 in Review

Clover Partners reduced its Synovus (SNV) stake by 58% in Q3 2019, selling an estimated $1.24M and leaving 25,396 shares worth $908K. The position accounts for 2.11% of the portfolio, ranked #20.

Clover Partners first reported a position in SNV in Q4 2018 and has held it in 4 quarters since. The position peaked at $2.1M in Q2 2019. 389 funds tracked by Wall St. Rank hold SNV as of Q3 2019.

  • Clover Partners held 25,396 shares of Synovus worth $908K as of Q3 2019.
  • Clover Partners sold 34,604 Synovus shares in Q3 2019, an estimated $1.24M.
  • Synovus made up 2.11% of Clover Partners's portfolio in Q3 2019, its #20 holding.
  • Clover Partners first reported a position in Synovus in Q4 2018 and has held it in 4 quarters since.
  • Clover Partners's Synovus position peaked at $2.1M in Q2 2019.
  • 389 funds tracked by Wall St. Rank held Synovus as of Q3 2019.

Based on Clover Partners's 13F filing for Q3 2019, filed 12 Nov 2019.